Picture of Dermapharm Holding SE logo

DMP — Dermapharm Holding SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Brief: Dermapharm Holding FY Unadjusted EBITDA Up By 2.8%

March 10 (Reuters) - Dermapharm Holding SE DMPG.DE:

DERMAPHARM HOLDING SE - IN 2025, CONSOLIDATED REVENUE DECREASES TO EUR 1,165.0 MILLION (-1.3%)

DERMAPHARM HOLDING SE - FY UNADJUSTED EBITDA RISES BY 2.8% TO EUR 317.6 MILLION

Further company coverage: DMPG.DE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Dermapharm Holding SE

See all news